论文部分内容阅读
由于免疫抑制患者的增加 ,系统性真菌感染率随着增高。其治疗有一定的难度 ,病亡率很高。系统性真菌感染的处理又与浅部真菌感染处理明显不同 ,治疗药物具有许多毒副反应 ,近来已有低肾毒性的药物如两性霉素B脂质体等的问世。正确选择和应用抗真菌药物对深部真菌感染的治疗和预后起非常重要的作用。作者对系统性真菌感染的治疗现状与进展作一综述
Due to an increase in immunosuppressed patients, the systemic fungal infection rate increases. The treatment has a certain degree of difficulty, high mortality. Treatment of systemic fungal infections is significantly different from that of superficial fungal infections. Therapeutic drugs have many toxic and side effects. Recently, drugs that have low nephrotoxic effects such as amphotericin B liposomes have emerged. Correct choice and application of antifungal agents play a very important role in the treatment and prognosis of deep fungal infections. The author reviews the status and progress of the treatment of systemic fungal infections